The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Liver Care After Successful Hepatitis C Treatment

Back to News Homepage

Next

Government Impact of Hep C Drug Price Tag

Will Prisoners Be Denied New Hepatitis C Drugs?

March 26, 2014

Print this page

Learn more about the costly advances in Hepatitis C treatment, and the ethical dilemma it now poses for eradicating the virus from infected prisoners.
Will prisoners be denied hepatitis c treatment?

By Michael Ollove, Pew/Stateline Staff Writer

March 25, 2014

If used widely, a new generation of antiviral drugs has the potential to wipe out the deadly hepatitis C virus in the United States. But the high price of the drugs might prevent their use in prisons, which house as many as one-third of those who are infected.

The drugs cost anywhere from about $65,000 to $170,000 for a single course of treatment—between three and nine times more than earlier treatments. Ronald Shansky, former medical director of the Illinois prison system and founder of the Society of Correctional Physicians, described that price as “extortionarily high, criminal.”

Fair or not, the cost of the new drugs is likely to keep them out of reach for most infected prisoners. To put the price in perspective, the average annual cost for states to house an inmate is $29,141. The minimal cost of treating a single patient with the new hepatitis C drugs is more than double that amount.

Continue reading this entire article:
http://www.usatoday.com/story/news/nation/2014/03/25/stateline-prisoners-hepatitis-drugs/6871187/

6 Comments
Share
Share

Previous

Liver Care After Successful Hepatitis C Treatment

Back to News Homepage

Next

Government Impact of Hep C Drug Price Tag

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.